company background image
QGMD

Qatari German Company for Medical Devices (Q.P.S.C.) DSM:QGMD Stock Report

Last Price

ر.ق1.77

Market Cap

ر.ق203.9m

7D

16.9%

1Y

-41.5%

Updated

07 Aug, 2022

Data

Company Financials
QGMD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health0/6
Dividends0/6

QGMD Stock Overview

Qatari German Company for Medical Devices (Q.P.S.C.) manufactures and sells single use disposable syringes in the Middle East.

Qatari German Company for Medical Devices (Q.P.S.C.) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Qatari German Company for Medical Devices (Q.P.S.C.)
Historical stock prices
Current Share Priceر.ق1.77
52 Week Highر.ق4.13
52 Week Lowر.ق1.35
Beta2.69
1 Month Change22.57%
3 Month Change-16.03%
1 Year Change-41.54%
3 Year Change181.05%
5 Year Change116.56%
Change since IPO-26.27%

Recent News & Updates

Aug 02
Qatari German Company for Medical Devices (Q.P.S.C.) (DSM:QGMD) Shareholders Will Want The ROCE Trajectory To Continue

Qatari German Company for Medical Devices (Q.P.S.C.) (DSM:QGMD) Shareholders Will Want The ROCE Trajectory To Continue

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Shareholder Returns

QGMDQA Medical EquipmentQA Market
7D16.9%1.2%2.9%
1Y-41.5%-26.1%16.6%

Return vs Industry: QGMD underperformed the QA Medical Equipment industry which returned -26.1% over the past year.

Return vs Market: QGMD underperformed the QA Market which returned 16.6% over the past year.

Price Volatility

Is QGMD's price volatile compared to industry and market?
QGMD volatility
QGMD Average Weekly Movement7.8%
Medical Equipment Industry Average Movement5.9%
Market Average Movement4.6%
10% most volatile stocks in QA Market7.0%
10% least volatile stocks in QA Market3.1%

Stable Share Price: QGMD is more volatile than 90% of QA stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: QGMD's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of QA stocks.

About the Company

FoundedEmployeesCEOWebsite
2000n/aEisa Al-Maslamanihttps://www.qgmd.com

Qatari German Company for Medical Devices (Q.P.S.C.) manufactures and sells single use disposable syringes in the Middle East. The company offers Q JectUltra, an insulin syringe serving as a tool in diabetic care; Q Flow for infusion therapy; Q Need, a single use hypodermic needle; Q Ject, a single use syringe for the curative medications; and Q Safe, a re-use prevention syringe. It also trades in medical consumables, medical equipment, medical furniture, tools, and supplies.

Qatari German Company for Medical Devices (Q.P.S.C.) Fundamentals Summary

How do Qatari German Company for Medical Devices (Q.P.S.C.)'s earnings and revenue compare to its market cap?
QGMD fundamental statistics
Market Capر.ق203.86m
Earnings (TTM)ر.ق1.23m
Revenue (TTM)ر.ق41.90m

165.4x

P/E Ratio

4.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
QGMD income statement (TTM)
Revenueر.ق41.90m
Cost of Revenueر.ق30.55m
Gross Profitر.ق11.34m
Other Expensesر.ق10.11m
Earningsر.ق1.23m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

Aug 10, 2022

Earnings per share (EPS)0.011
Gross Margin27.07%
Net Profit Margin2.94%
Debt/Equity Ratio427.7%

How did QGMD perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is QGMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for QGMD?

Other financial metrics that can be useful for relative valuation.

QGMD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue8.2x
Enterprise Value/EBITDA29.5x
PEG Ration/a

Price to Sales Ratio vs Peers

How does QGMD's PS Ratio compare to its peers?

QGMD PS Ratio vs Peers
The above table shows the PS ratio for QGMD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPSEstimated GrowthMarket Cap
Peer Average0.4x
COMFORT Comfort Gloves Berhad
0.2xn/aRM298.5m
546 Medtecs International
0.5x-0.6%S$102.4m
8K7 UG Healthcare
0.4x-9.2%S$131.0m
CAREPLS Careplus Group Berhad
0.4xn/aRM242.7m
QGMD Qatari German Company for Medical Devices (Q.P.S.C.)
4.9xn/aر.ق203.9m

Price-To-Sales vs Peers: QGMD is expensive based on its Price-To-Sales Ratio (4.9x) compared to the peer average (0.4x).


Price to Earnings Ratio vs Industry

How does QGMD's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

Price-To-Sales vs Industry: QGMD is expensive based on its Price-To-Sales Ratio (4.9x) compared to the Asian Medical Equipment industry average (3.3x)


Price to Sales Ratio vs Fair Ratio

What is QGMD's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

QGMD PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio4.9x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate QGMD's Price-To-Sales Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of QGMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: QGMD (QAR1.77) is trading above our estimate of fair value (QAR1.1)

Significantly Below Fair Value: QGMD is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Qatari German Company for Medical Devices (Q.P.S.C.) forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.4%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Qatari German Company for Medical Devices (Q.P.S.C.) has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Take a look at our analysis of QGMD’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.

Past Performance

How has Qatari German Company for Medical Devices (Q.P.S.C.) performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


44.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: QGMD has high quality earnings.

Growing Profit Margin: QGMD's current net profit margins (2.9%) are lower than last year (12.7%).


Past Earnings Growth Analysis

Earnings Trend: QGMD has become profitable over the past 5 years, growing earnings by 44.6% per year.

Accelerating Growth: QGMD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: QGMD had negative earnings growth (-67%) over the past year, making it difficult to compare to the Medical Equipment industry average (10.8%).


Return on Equity

High ROE: QGMD's Return on Equity (3.7%) is considered low.


Discover strong past performing companies

Financial Health

How is Qatari German Company for Medical Devices (Q.P.S.C.)'s financial position?

Financial Health Score

0/6

Financial Health Score 0/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: QGMD's short term assets (QAR53.0M) do not cover its short term liabilities (QAR73.8M).

Long Term Liabilities: QGMD's short term assets (QAR53.0M) do not cover its long term liabilities (QAR78.8M).


Debt to Equity History and Analysis

Debt Level: QGMD's net debt to equity ratio (414.5%) is considered high.

Reducing Debt: QGMD's debt to equity ratio has increased from 149.3% to 427.7% over the past 5 years.

Debt Coverage: QGMD's debt is not well covered by operating cash flow (4.9%).

Interest Coverage: QGMD's interest payments on its debt are not well covered by EBIT (1.3x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Qatari German Company for Medical Devices (Q.P.S.C.) current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate QGMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate QGMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if QGMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if QGMD's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: QGMD is not paying a notable dividend for the QA market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as QGMD has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Eisa Al-Maslamani

no data

Tenure

Mr. Eisa Khalid Al-Maslamani serves as Managing Director and Executive Director at Qatari German Company for Medical Devices Q.P.S.C. He served as Independent Director at Qatari German Company for Medical...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Qatari German Company for Medical Devices (Q.P.S.C.)'s employee growth, exchange listings and data sources


Key Information

  • Name: Qatari German Company for Medical Devices (Q.P.S.C.)
  • Ticker: QGMD
  • Exchange: DSM
  • Founded: 2000
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Implied Market Cap: ر.ق203.858m
  • Shares outstanding: 115.50m
  • Website: https://www.qgmd.com

Location

  • Qatari German Company for Medical Devices (Q.P.S.C.)
  • Building Number 136
  • Street Number 54
  • Doha
  • Qatar

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/07 00:00
End of Day Share Price2022/08/07 00:00
Earnings2022/03/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.